Zobrazeno 1 - 10
of 463
pro vyhledávání: '"Louis Lasagna"'
Autor:
Louis Lasagna
Publikováno v:
Controversies in Alcoholism and Substance Abuse ISBN: 9781003282822
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9e6934d245f8e99fa63569cf5eb60ff
https://doi.org/10.4324/9781003282822-7
https://doi.org/10.4324/9781003282822-7
Autor:
Louis Lasagna
Publikováno v:
The Dying Patient ISBN: 9780429338977
A variety of factors will modify both the frequency of prognostication and its accuracy. To begin with, there is the element of diagnostic skill. Obviously, the physician who does not recognize that a patient’s life is threatened will not manifest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf6bf377da7b613a7d6ed36caed920cb
https://doi.org/10.4324/9780429338977-6
https://doi.org/10.4324/9780429338977-6
Autor:
Louis Lasagna
Publikováno v:
The Dying Patient ISBN: 9780429338977
The physician has good reason to anticipate that his therapeutic ministrations may be less effective in elderly patient. Old age, with its accumulated physical insults to the body, is often associated with a decreased resiliency, a diminished reserve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8cdbade9f791dffaeb3e12a667c2f3d7
https://doi.org/10.4324/9780429338977-7
https://doi.org/10.4324/9780429338977-7
Autor:
Neal E. Miller, Harry Grundfest, Amedeo S. Marrazzi, Zigmond M. Lebensohn, O. V. Kerbikov, K. F. Killam, Louis Lasagna, V. V. Zakusov, Louis Kline, Heinz H. Lehmann
Publikováno v:
Annals of the New York Academy of Sciences. 92:1017-1045
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d9bf5fb56bcd8d32edc07e4b2c61abb
https://doi.org/10.1111/j.1749-6632.1961.tb40974.x
https://doi.org/10.1111/j.1749-6632.1961.tb40974.x
Autor:
Heinz H. Lehmann, Louis Lasagna, A.V. Snezhnevsky, Nathan S. Kline, George M. Simpson, Fred A. Mettler, Enoch Callaway, O. V. Kerbikov
Publikováno v:
Annals of the New York Academy of Sciences. 92:1122-1140
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e929b019acf6c08540775d4fe4f8f66b
https://doi.org/10.1111/j.1749-6632.1961.tb40982.x
https://doi.org/10.1111/j.1749-6632.1961.tb40982.x
Autor:
Sheila R. Shulman, Louis Lasagna
Publikováno v:
Journal of Pharmaceutical Marketing & Management. 12:1-6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28a7881d210d3d4d24b7735d5d445fad
https://doi.org/10.3109/j058v12n02_01
https://doi.org/10.3109/j058v12n02_01
Autor:
Louis Lasagna
Publikováno v:
Clinical Research and Regulatory Affairs. 14:39-42
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbdf587e6278c49cca9fc09f4aae7269
https://doi.org/10.3109/10601339709019438
https://doi.org/10.3109/10601339709019438
Publikováno v:
Drug Information Journal. 30:315-337
Food and Drug Administration (FDA) review times for supplemental indications of already-approved new chemical entities (NCEs) were compared to the review times for their associated original indications. The data show that mean supplemental indication
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::346473ca45e6ff869d583f2ff07d2e13
https://doi.org/10.1177/009286159603000201
https://doi.org/10.1177/009286159603000201